Are Rihanna's extra-curricular activities becoming a hazard to her health? After partying the night away in high fashion at the Costume Institute Gala at New York City's Metropolitan Museum of Art, the pop singer was rushed to the ER and hospitalized. The day after the event, she tweeted a photo of her arm hooked up to an IV drip. What happened to Rihanna between the red carpet and the hospital bed?
There are many types of loans out there, but they can generally be divided into two categories: secured and unsecured loans. Some experts recommend one kind over the other, but most generally agreed that both can be good in certain situations and under certain circumstances. This latter opinion is the correct one, as there are many times when a secured loan is really the best and only options, while there are many others where it?s easier and smarter to just get an unsecured loan. How can you tell the two cases apart and make the right decision that your situation warrants? Hopefully this guide can help you to decide.
What They Mean
First of all, get an understanding of what each of these types of loans will mean for you.
Begin with secured loans: they require you to give some sort of security to ensure that repayment will be made. Oftentimes the security will be something like your house or car, or something valuable to that effect. Gold and jewelry are also used as security.
Secured loans are better in some ways because they offer lower interest rates and potentially longer repayment periods. For that reason, these loans are usually taken out for huge amounts of money and important purposes. They also require a more demanding application process, and not everyone is usually qualified to receive one of these.
Unsecured loans are a different matter. The biggest difference is in the fact that no security is required. You are given the loan because the lender (after looking at your financial history) trusts that you will repay. You don?t have to give them anything.
This also means higher interest, shorter durations, but ultimately an easier loan process. Just about anyone can qualify to get?open door loans?or other similar unsecured loans just as long as they don?t have a terrible credit history. Best of all, you can often get the money you need in a matter of days; with some loans like open door loans, that wait period can be just a few hours.
Choosing Between Secured and Unsecured
Which loan you choose depends on what you need the loan for, how big you want the loan to be, and how long you want to go without fully repaying. If you want money for only a short period of time, then get open door loans and other unsecured loans. If you want a big loan for something like an investment or a down payment, stick with the safer and longer-term option. Once you understand these two types of loans, it?s much easier to make your decision.
Third time's a charm... Three's a crowd... She's once, twice, three times a lady Nexus... Three's a magic number... Good things come in threes... or is that sneezes? Okay, so maybe there isn't anything clever we can say to get you hooked, but do we really need to lure you in at this point? The Galaxy Nexus is, arguably, not only one of the best Android phones on the market, but one of the best phones, period. So, there's no reason to expect the Sprint variant ($199 on contract) would be anything short of incredible. Still, there's only one way to find out. Follow along after the break as we put the newest member of the Nexus family through its paces and see how it stacks up against its Verizon and unlocked siblings.
Costs of screening children for sudden cardiac death outweigh its benefitsPublic release date: 9-May-2012 [ | E-mail | Share ]
Contact: Randi Triant rtriant@tuftsmedicalcenter.org 617-636-9845 Tufts Clinical and Translational Science Institute
Boston, MA An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents. The authors found that screening can save lives, but that because it targets rare conditions and available tests have limited accuracy, screening for SCD is costly, compared to other life-saving measures.
Although rare, SCD often receives widespread attention because it is unexpected and can occur during childhood. Those factors have prompted many parents and policy makers to support screening programs. To help decision makers and the public understand whether more SCD screening is warranted, the authors, including collaborating clinical researchers from Children's Hospital Boston, compared the potential life saving benefits (measured in terms of life years saved) to program costs. They considered two groups thought to be at elevated risk: school-aged children taking stimulants, which are often used to treat Attention Deficit Hyperactivity Disorder (ADHD), and adolescents playing organized sports. The research team determined that each year of life saved would cost from $90,000 (to screen adolescents before they participate in sports) to $200,000 (to screen children before they take ADHD medications).
Although there is no hard and fast line separating worthwhile and expensive public health interventions, programs can be compared to get an idea of their value. For example, interventions that cost $90,000 to $200,000 per life year saved are considered expensive, compared to other interventions, which often save life years at $50,000 to $100,000, or even less. The results of this study suggest that finite public health resources might be better spent elsewhere.
The "human cost" of screening suggests its true price may be even higher. Because conditions causing SCD are so rare, even an occasional "false positive" means that for every previously undiagnosed child accurately identified, many children who would never have died from SCD may be labeled as being at-risk.
The research team stressed that the cardiac conditions causing SCD in children are incredibly rare. Many are cardiac conditions are genetic and there may be a family history of early (
###
Funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, the study involved building simulation models incorporating disease prevalence, ECG characteristics, treatment algorithms, and diagnostic and treatment costs to determine the cost-effectiveness ratios. The research team included health policy, health economics, and decision-analytics researchers from Tufts Medical Center and pediatric cardiologists at Children's Hospital Boston. Additional support for the study was provided by the Tufts CTSI, the John R. Grey IV Cardiology Fellowship Endowment Fund, and the Sean Roy Johnson Fund for Electrophysiology Research. The article is available through the journal's website.
About the NIH
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. Helping to lead the way toward important medical discoveries that improve people's health and save lives, NIH scientists investigate ways to prevent disease as well as the causes, treatments, and even cures for common and rare diseases. Composed of 27 Institutes and Centers, the NIH provides leadership and financial support to researchers in every state and throughout the world. For more information about NIH and its programs, visit www.nih.gov.
About Tufts Clinical and Translational Science Institute (CTSI)
Tufts CTSI was established in August 2008 with Grant Number UL1 RR025752 from the National Center for Research Resources, now the National Center for Advancing Translational Sciences, National Institutes of Health. A collaboration of organizations, founded by Tufts Medical Center and Tufts University, Tufts CTSI accelerates the translation of laboratory research into clinical use, medical practice and health policy. It connects people to research resources, consultation, and education, and fosters collaboration with scholars of all disciplines and with community members, with the ultimate goal of improving the health of the public. Website: www.tuftsctsi.org.
About Tufts Medical Center
Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating Hospital for Children. Located in downtown Boston, the Medical Center is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with seven community hospitals and with New England Quality Care Alliance, its community physicians' network. For more information, please visit www.tuftsmedicalcenter.org.
About Children's Hospital Cardiovascular Program
The Cardiovascular Program at Children's is the largest pediatric heart program in the United States. For more than 50 years, Children's cardiac specialists and investigators have played a vital role in the field of cardiac research, pioneering treatment approaches and major advances in the care and treatment of children with congenital and acquired heart defects.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Costs of screening children for sudden cardiac death outweigh its benefitsPublic release date: 9-May-2012 [ | E-mail | Share ]
Contact: Randi Triant rtriant@tuftsmedicalcenter.org 617-636-9845 Tufts Clinical and Translational Science Institute
Boston, MA An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents. The authors found that screening can save lives, but that because it targets rare conditions and available tests have limited accuracy, screening for SCD is costly, compared to other life-saving measures.
Although rare, SCD often receives widespread attention because it is unexpected and can occur during childhood. Those factors have prompted many parents and policy makers to support screening programs. To help decision makers and the public understand whether more SCD screening is warranted, the authors, including collaborating clinical researchers from Children's Hospital Boston, compared the potential life saving benefits (measured in terms of life years saved) to program costs. They considered two groups thought to be at elevated risk: school-aged children taking stimulants, which are often used to treat Attention Deficit Hyperactivity Disorder (ADHD), and adolescents playing organized sports. The research team determined that each year of life saved would cost from $90,000 (to screen adolescents before they participate in sports) to $200,000 (to screen children before they take ADHD medications).
Although there is no hard and fast line separating worthwhile and expensive public health interventions, programs can be compared to get an idea of their value. For example, interventions that cost $90,000 to $200,000 per life year saved are considered expensive, compared to other interventions, which often save life years at $50,000 to $100,000, or even less. The results of this study suggest that finite public health resources might be better spent elsewhere.
The "human cost" of screening suggests its true price may be even higher. Because conditions causing SCD are so rare, even an occasional "false positive" means that for every previously undiagnosed child accurately identified, many children who would never have died from SCD may be labeled as being at-risk.
The research team stressed that the cardiac conditions causing SCD in children are incredibly rare. Many are cardiac conditions are genetic and there may be a family history of early (
###
Funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, the study involved building simulation models incorporating disease prevalence, ECG characteristics, treatment algorithms, and diagnostic and treatment costs to determine the cost-effectiveness ratios. The research team included health policy, health economics, and decision-analytics researchers from Tufts Medical Center and pediatric cardiologists at Children's Hospital Boston. Additional support for the study was provided by the Tufts CTSI, the John R. Grey IV Cardiology Fellowship Endowment Fund, and the Sean Roy Johnson Fund for Electrophysiology Research. The article is available through the journal's website.
About the NIH
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. Helping to lead the way toward important medical discoveries that improve people's health and save lives, NIH scientists investigate ways to prevent disease as well as the causes, treatments, and even cures for common and rare diseases. Composed of 27 Institutes and Centers, the NIH provides leadership and financial support to researchers in every state and throughout the world. For more information about NIH and its programs, visit www.nih.gov.
About Tufts Clinical and Translational Science Institute (CTSI)
Tufts CTSI was established in August 2008 with Grant Number UL1 RR025752 from the National Center for Research Resources, now the National Center for Advancing Translational Sciences, National Institutes of Health. A collaboration of organizations, founded by Tufts Medical Center and Tufts University, Tufts CTSI accelerates the translation of laboratory research into clinical use, medical practice and health policy. It connects people to research resources, consultation, and education, and fosters collaboration with scholars of all disciplines and with community members, with the ultimate goal of improving the health of the public. Website: www.tuftsctsi.org.
About Tufts Medical Center
Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating Hospital for Children. Located in downtown Boston, the Medical Center is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with seven community hospitals and with New England Quality Care Alliance, its community physicians' network. For more information, please visit www.tuftsmedicalcenter.org.
About Children's Hospital Cardiovascular Program
The Cardiovascular Program at Children's is the largest pediatric heart program in the United States. For more than 50 years, Children's cardiac specialists and investigators have played a vital role in the field of cardiac research, pioneering treatment approaches and major advances in the care and treatment of children with congenital and acquired heart defects.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
WHEN:????????? ??????????? 11:00 AM THURSDAY MAY 31ST 2012
?HOW:???????????????????????? LEARN HOW TO IMPROVE IN THE FOLLOWING:
GOAL SETTING-MENTAL VS WRITTEN, SPECIFIC & ACHIEVABLE
ATTITUDE-KEYS TO ESTABLISHING ?LIKE & TRUST?
PROSPECTING & INTIAL CONTACT
NEEDS ANALYSIS & DISCOVERY PROBING
PRESENTATION SKILLS AND OVERCOMING OBJECTIONS
THE CLOSE & FOLLOW UP
HOW TO GIVE AND RECEIVE BETTER REFERRALS
PLUS MANY MORE IDEAS TO EXPLODE YOUR BUSINESS in 2012
Our National Senior Trainer, Steve Black, is the architect behind several of the fastest growing training and internet firms. He can teach your members traditional sales skills and also cutting edge techniques to get more business. Steve is regarded to be one of the nation?s best sales trainers and public speakers. He has toured with Brian Tracy and Tom Hopkins for many years and has spoken to approximately 500,000 people across the Country.
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have gained important new insights into how our sense of hearing works. Their findings promise new avenues for scientists to understand what goes wrong when people experience deafness. Their findings are published in Royal Society Open Biology, a new open access journal.
The team was led by Prof John Wood of UCL (University College London). Professor Wood explains: "As many people will already know, our ears are filled with tiny hair cells that move in response to the pressure of a sound wave. But exactly what happens within cells to turn that movement into an electrical signal that our brains' can interpret as sound has been puzzling scientists for decades. Our findings have given us some new insights into the puzzle."
The UCL team found that when mice lack two proteins, called TRPC3 and TRPC6, they experience about an 80% drop in their ability to detect high frequency sounds. Intriguingly, the loss of these two proteins also makes the mice slightly less sensitive to light touch sensations. When the mice that lack these proteins are brushed lightly, a third of the nerve cells which would normally fire remain inactive. This finding suggests an important link between how our bodies sense touch and sound.
Only when both TRPC3 and TRPC6 were absent was the mice's hearing and sense of touch impaired; the loss of each protein on its own had no behavioural effect on the mice. This suggests that the proteins are only parts of a more complex mechanism used in detecting sound and touch.
Professor Wood continues: "We are still a long way from a complete understanding of touch and hearing but this is a really exciting lead. Our next step is to find out what other proteins are involved in this mechanism and how they all interact. Hopefully then, once we know how the mechanism works in people who can hear, we can understand what goes wrong in people who can't."
The two proteins, TRPC3 and TRPC6, seem to be able to make a pressure-sensitive ion channel in some cells but not others. In response to tiny pressures, this channel would allow the flow of electrical signals but seems to require some, as yet uncharacterised, additional factor. This research adds to our knowledge of the potential components required for sound transduction in hair cells and provides us with molecular tools to find other interacting proteins that may play a crucial role in hearing.
Professor Wood received the funding to do this work as part of a Longer and Larger award (LoLa) from BBSRC. These provide leading research teams with the time and resources to tackle major scientific questions.
Professor Douglas Kell, BBSRC Chief Executive, said, "Human biology still holds many secrets and there are big gaps in our understanding of even fundamental processes like touch, pain and hearing. As scientists invent new techniques and technologies we are able to investigate the fundamentals of human biology in exciting new ways. This is crucial because only by deepening our understanding of how our bodies work can we find new ways of helping people when things go wrong."
###
Biotechnology and Biological Sciences Research Council: http://www.bbsrc.ac.uk
Thanks to Biotechnology and Biological Sciences Research Council for this article.
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Having made it very clear just what Starships are meant to do, Nicki Minaj has come out with her new Pepsi commercial.
In the ad, the eccentric artist sings a remixed version of the track "Moment 4 Life," while various individuals suddenly find themselves appropriately frozen in time. What do they do with these moments? They screw up a beach volleyball game, they steal clothing from a fashion show and they sneak into a Minaj concert.
And they drink Pepsi, of course. Are you inspired by the spot? View an extended cut of it now: